“The index rose 0.97% to 52,017, with gains broadening through the session as cash market liquidity improved,” analysts noted, highlighting a recovery in the Nikkei 225 after a tumultuous two-day period.

The Nikkei 225 rebounded by 501 points, recovering from a significant decline of over 3,700 points. This resurgence was primarily driven by strong performances in the pharmaceutical and metals sectors.

Leading the gains were Sumitomo Dainippon, which surged 6.70%, Astellas Pharma at 5.46%, and Sumitomo Metal Mining, which increased by 5.18%. However, not all stocks fared well; Nintendo Co was one of the weakest performers, declining by 4.12%.

The backdrop to this volatility includes a weaker yen, with the USDJPY exchange rate nearing 160. A weaker yen tends to lift exporters’ reported revenues and margins, which can support indices.

Market analysts have cautioned that the current environment remains challenging. “The market continues to be very noisy and difficult, but I think at this point in time you need to be very cautious about getting overly aggressive with any position size in any index around the world,” one analyst stated.

Japan’s financial authorities have also issued warnings regarding potential actions against disorderly foreign exchange movements, which adds another layer of uncertainty to the market.

Despite the recent rebound, volatility remains elevated, indicating that investors should remain vigilant. The Nikkei 225’s recovery is a welcome sign, but the underlying factors contributing to market fluctuations continue to pose risks.

As the situation develops, market participants will be closely monitoring both domestic and international economic indicators that could impact the Nikkei 225’s trajectory.

The post Nikkei 225 Rebounds After Two-Day Slide appeared first on newscri.